Development of a Novel Method to Detect AAV Vector Integration
Viruses · 03.03.2026 · 18 (3) · 315
DOI: 10.3390/v18030315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 03.03.2026. Verfasst von Junping Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA. Hauptthemen laut MEDLINE: Dependovirus, Genetic Vectors, Virus Integration. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Institute of Health, NHLBI NIH HHS, National Heart, Lung, and Blood Institute, the National Institutes of Health, the Department of Health and Human Services.
Abstract (Originalsprache)
AAV integration has become an important safety consideration in gene therapy. However, accurately determining integration sites remains challenging due to biases introduced by library preparation methods, sequencing technologies, and bioinformatic pipelines. In this study, we developed a PCR-free amplification based on a CRISPR-Cas9 cleavage strategy for AAV DNA that overcomes the limitations of PCR amplification imposed by the ITR structure. When combined with long-read nanopore sequencing, this CRISPR-Cas9-based workflow preserves native AAV integration states and enables unbiased detection of integration junctions. We used AAV-transduced HeLa single-cell clones to evaluate the performance of this approach. To confirm integration site identification, AAV integration junctions were also detected using a probe hybridization capture strategy followed by Illumina short-read sequencing. Integration junctions identified by both methods were further confirmed by PCR. The results showed strong consistency between the two approaches in accurately identifying AAV integration sites in each clone. Overall, these findings demonstrate that the CRISPR-Cas9-enabled, PCR-free long-read sequencing workflow provides a promising tool for characterizing AAV integration events.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA.
- Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
- Department of Computer Science, Cornell University, Ithaca, NY 14853, USA.
ORCID-Profile: Thao Thi Dang, Tsai-Yu Lin, Xiangping Yu, Jiahe Tian
Förderung
- National Institute of Health
- NHLBI NIH HHS
- National Heart, Lung, and Blood Institute, the National Institutes of Health, the Department of Health and Human Services
Zitieren
APA
Zhang, J., Dang, T. T., Lin, T. Y., Yu, X., Pellin, D., Tian, J., Simmons, O., Kou, E., Cornetta, K., & Xiao, W. (2026). Development of a Novel Method to Detect AAV Vector Integration. Viruses, 18(3), 315. https://doi.org/10.3390/v18030315
Vancouver
Zhang J, Dang TT, Lin TY, Yu X, Pellin D, Tian J, et al. Development of a Novel Method to Detect AAV Vector Integration. Viruses. 2026;18(3):315. doi:10.3390/v18030315
BibTeX
@article{Zhang2026,
author = {Zhang, Junping and Dang, Thao Thi and Lin, Tsai-Yu and Yu, Xiangping and Pellin, Danilo and Tian, Jiahe and Simmons, Olga and Kou, Emma and Cornetta, Kenneth and Xiao, Weidong},
title = {Development of a Novel Method to Detect AAV Vector Integration},
journal = {Viruses},
year = {2026},
volume = {18},
number = {3},
pages = {315},
doi = {10.3390/v18030315}
}
EUVIMED